Meteorin Is a Novel Interaction Partner of p60-Katanin During Mitosis in HCT-116 Colorectal Cancer Cells

Ilgin Isiltan1,2, Arzu Karabay1,2

  • 1Molecular Biology-Genetics and Biotechnology, Graduate School, Istanbul Technical University, Istanbul, Turkey.

PubMed

Insights

Meteorin interacts with p60-Katanin, a microtubule-severing protein, during cell division in colorectal cancer cells. Depleting Meteorin reduces cancer cell proliferation, highlighting its role in cell cycle progression.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Microtubule dynamics are crucial for cellular functions, regulated by proteins like p60-Katanin.
  • p60-Katanin is a microtubule-severing protein vital for cell division and microtubule remodeling.
  • Colorectal cancer (CRC) progression involves complex cellular mechanisms.

Purpose of the Study:

  • To identify novel interaction partners of p60-Katanin in colorectal cancer cells.
  • To investigate the role of Meteorin in cell division and proliferation of CRC cells.
  • To explore the relationship between Meteorin, p60-Katanin, and TP53 in CRC.

Main Methods:

  • Co-immunoprecipitation to identify protein interactions.
  • Immunofluorescence microscopy to determine protein localization during mitosis.
  • RNA interference (siRNA) to silence Meteorin expression.
  • Cell proliferation assays.

Main Results:

  • Meteorin was identified as a novel interaction partner of p60-Katanin in HCT-116 CRC cells.
  • Meteorin localizes to spindle poles throughout mitosis and co-localizes with p60-Katanin.
  • Meteorin silencing reduced HCT-116 and HCT-116 p53 (-/-) cell proliferation.
  • Meteorin levels influenced p60-Katanin expression, with silencing decreasing it and overexpression increasing it in TP53-expressing cells.

Conclusions:

  • Meteorin interacts with p60-Katanin and localizes to spindle poles during mitosis in CRC cells.
  • Meteorin depletion inhibits CRC cell proliferation independently of TP53 status.
  • Meteorin plays a significant role in regulating p60-Katanin expression and microtubule dynamics in colorectal cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.3K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Attachment of Sister Chromatids02:57

Attachment of Sister Chromatids

As cells progress into mitosis, the nuclear envelope breaks down, and the condensed chromosomes are exposed to the array of bipolar microtubules of the mitotic spindle. The kinetochore, a large, disc-shaped protein complex, is present at the centromere region of the sister chromatids and acts as a binding site for the microtubules.  Usually, the plus-end of a single microtubule is embedded within the kinetochore. However, some kinetochores first establish lateral contact with the side-wall...
3.9K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K